CrowdStrike (NASDAQ:CRWD) stock is in the news Wednesday as the cybersecurity company announced Michael Sentonas as its new president.
Sentonas is being promoted to the president role after serving as CTO of CrowdStrike since 2022. He’s been with the company since 2016 when he joined as the vice president of Technology Strategy.
With this promotion, Sentonas will report directly to co-founder and CEO George Kurtz. This change will also have the company’s CSO, CMO, chief product & engineering officer, and senior vice president of Intelligence report directly to Sentonas.
Kurtz said the following about Sentonas taking on the role of president at CrowdStrike:
“Mike is a tremendous partner and will continue helping me drive the company to our next level of growth. His unique skill set and leadership will allow me to engage even more with our customers and partners as we continue scaling CrowdStrike into a once-in-a-generation cybersecurity company.”
CRWD Stock Investor Reactions
Investors seem receptive to today’s news with shares of CRWD stock climbing 2.2% higher as of Wednesday morning. That comes as some 1 million shares of the stock change hands. For the record, the company’s daily average trading volume is closer to 5.4 million shares. It’s also worth mentioning that CRWD stock is up 13.9% since the start of the year.
Investors searching for all of the latest stock market news will want to stick around!
We’re offering up all of the hottest stock market coverage traders need to know about on Wednesday! That includes what’s going on with shares of Tripadvisor (NASDAQ:TRIP), Alibaba (NYSE:BABA), and Lixte Biotech (NASDAQ:LIXT) stock today. You can read up on all of these matters at the links below!
More Wednesday Stock Market News
- Tripadvisor (TRIP) Stock Receives Double Upgrade From Bank of America
- BABA Stock Alert: Alibaba Tests AI Tool to Compete With ChatGPT
- Why Is Lixte Biotech (LIXT) Stock Down 29% Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.